The Long Run with Luke Timmerman podcast

Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

0:00
1:02:28
Recuar 15 segundos
Avançar 15 segundos
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.

Mais episódios de "The Long Run with Luke Timmerman"